ACCOUNTING POLICIES (Details Narrative) - USD ($) |
3 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Feb. 28, 2025 |
May 31, 2026 |
May 31, 2025 |
Feb. 28, 2026 |
Feb. 28, 2025 |
May 04, 2026 |
Apr. 20, 2026 |
Mar. 25, 2026 |
|
| Product Information [Line Items] | ||||||||
| Loans payable | $ 32,801,345 | $ 35,722,326 | $ 33,672,294 | $ 32,801,345 | $ 700,000 | $ 277,778 | $ 630,000 | |
| Allowance for doubtful accounts receivable | 140,000 | 240,000 | 170,000 | 140,000 | ||||
| Inventory valuation reserves | $ 465,000 | $ 175,000 | $ 175,000 | 465,000 | ||||
| Description of deferred tax assets and liabilities | The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. A corresponding offset has been made to the valuation allowance, and any potential other taxes arising due to the Tax Act will result in reductions to the Company’s net operating loss carryforward and valuation allowance. The Company will continue to analyze the Tax Act to assess its full effects on the Company’s financial results, including disclosures, for the Company’s fiscal year ending February 28, 2027, but the Company does not expect the Tax Act to have a material impact on the Company’s consolidated financial statements. | The Company’s gross deferred tax assets were revalued based on the reduction in the federal statutory tax rate from 35% to 21%. A corresponding offset has been made to the valuation allowance, and any potential other taxes arising due to the Tax Act will result in reductions to the Company’s net operating loss carryforward and valuation allowance. The Company will continue to analyze the Tax Act to assess its full effects on the Company’s financial results, including disclosures, for the Company’s fiscal year ending February 28, 2026, but the Company does not expect the Tax Act to have a material impact on the Company’s consolidated financial statements. | ||||||
| Incentive Compensation Plan [Member] | ||||||||
| Product Information [Line Items] | ||||||||
| Payment for stock based compensation warrants | $ 0 | $ 0 | $ 1,500,000 | $ 1,500,000 | ||||
| Two Customer [Member] | ||||||||
| Product Information [Line Items] | ||||||||
| Percentage of revenue | 36.00% | 55.00% | ||||||
| One Customer [Member] | ||||||||
| Product Information [Line Items] | ||||||||
| Percentage of revenue | 55.00% | 65.00% | 55.00% | |||||
| Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customer [Member] | ||||||||
| Product Information [Line Items] | ||||||||
| Percentage of accounts receivable | 23.00% | 31.00% | ||||||
| Accounts Receivable [Member] | Customer Concentration Risk [Member] | One Customer [Member] | ||||||||
| Product Information [Line Items] | ||||||||
| Percentage of accounts receivable | 52.00% | |||||||
| Accounts Receivable [Member] | Customer Concentration Risk [Member] | Three Customer [Member] | ||||||||
| Product Information [Line Items] | ||||||||
| Percentage of accounts receivable | 53.00% | |||||||
| Controller [Member] | ||||||||
| Product Information [Line Items] | ||||||||
| Loans additions | $ 28,581,506 | $ 32,466,506 | $ 32,178,506 | |||||
| Loans percentage | 87.00% | 91.00% | 96.00% | 87.00% | ||||